{"schema_version":"secwatch.filing_event.v1","accession":"0000917520-23-000008","form_type":"8-K","ticker":"IART","cik":"0000917520","company_name":"INTEGRA LIFESCIENCES HOLDINGS CORP","filed_at":"2023-01-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:48.566775+00:00","generated_at":"2026-06-20T10:17:47.612771+00:00","sec_items":["2.02"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Integra LifeSciences raises adj EPS guidance for Q4 and FY2022 above prior expectations","bullets":["Q4 2022 adjusted EPS expected $0.92-$0.96 vs $0.84 in Q4 2021; above Oct guidance high end.","FY 2022 adjusted EPS expected $3.34-$3.38 vs $3.18 in FY 2021; above Oct guidance high end.","Preliminary, unaudited results; full Q4 & FY 2022 earnings due Feb 22, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0000917520-23-000008","json":"https://secwatch.observer/filing/0000917520-23-000008.json","markdown":"https://secwatch.observer/filing/0000917520-23-000008.md","text":"https://secwatch.observer/filing/0000917520-23-000008.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/917520/000091752023000008/0000917520-23-000008-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/917520/000091752023000008/iart-20230125.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T10:17:47.612771+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6ae207000ac86d50bc95a643debe9ef77039fe5e","claim":"INTEGRA LIFESCIENCES HOLDINGS CORP reported fourth quarter 2022 results: EPS $0.92 to $0.96. Guidance raised.","evidence_excerpt":"Fourth quarter 2022 adjusted earnings per diluted share is expected to be in a range of $0.92 to $0.96 compared to $0.84 in 2021.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/917520/000091752023000008/0000917520-23-000008-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter 2022"},{"label":"EPS","value":"$0.92 to $0.96"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"},{"claim_id":"cc0f81e7ce8184144af6b04563af627cd1df737d","claim":"INTEGRA LIFESCIENCES HOLDINGS CORP reported full-year 2022 results: EPS $3.34 to $3.38. Guidance raised.","evidence_excerpt":"Full-year 2022 adjusted earnings per diluted share is expected to be in a range of $3.34 to $3.38 compared to $3.18 in 2021.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/917520/000091752023000008/0000917520-23-000008-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full-year 2022"},{"label":"EPS","value":"$3.34 to $3.38"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}